FRUZAQLA is not chemotherapy. It is a targeted therapy that affects vascular endothelial growth factor (VEGF) receptors, ...

FDA posts update as mechanism to obtain unapproved Domperidone expected to lose supply in early 2025 Gimoti remains only ...

Bracco Diagnostics Inc. (BDI), a U.S. subsidiary of Bracco Imaging S.p.A., one of the world's leading companies in the diagnostic imaging business, and a pioneer in healthcare innovation, proudly ...

3 Pain Research, Nuffield Department of Anaesthetics, University of Oxford, Level 6 West Wing, John Radcliffe Hospital, Headington, Oxford, OX3 9DU, UK Email: Martin R Tramèr - martin.tramer@ ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it will receive a US$10 million milestone payment by its partner Takeda (TSE:4502/NYSE:TAK). Takeda received a national ...

Deep and large perforations, as well as fistulas and difficult bleeds, can effectively be approached with these devices. They will become important tools in busy endoscopy units.

It also minimizes the chance of complications, including colon perforation, which occurs in 1in 1,000 traditional colonoscopies. The procedure can also identify other health issues outside the ...